41 results
8-K
EX-10.1
5i2bri h2s5w1x
12 Oct 22
Entry into a Material Definitive Agreement
8:49am
8-K
EX-99.1
tp438wp570bwrob
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-10.1
pfmnxpjr1xjzse
20 Mar 20
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19
11:43am
DRS/A
zvxpmmrc9n8zbdo5o2
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
zzh4acj629 5b
14 Oct 16
IPO registration
12:00am